Cargando…
Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non–Small-Cell Lung Cancer
Background: The intervention timing of immune checkpoint inhibitors (ICIs) and radiotherapy fractionations are critical factors in clinical efficacy. This study aims to explore dynamic changes of the tumor immune microenvironment (TIME) after hypofractionated radiotherapy (HFRT) at different timepoi...
Autores principales: | Zhao, Xianlan, Li, Jixi, Zheng, Linpeng, Yang, Qiao, Chen, Xu, Chen, Xiewan, Yu, Yongxin, Li, Feng, Cui, Jianxiong, Sun, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819084/ https://www.ncbi.nlm.nih.gov/pubmed/35141280 http://dx.doi.org/10.3389/fmolb.2022.786864 |
Ejemplares similares
-
Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis
por: Yang, Qiao, et al.
Publicado: (2019) -
Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
por: Xu, Zihan, et al.
Publicado: (2019) -
Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016) -
Optimization of a small molecule inhibitor of secondary nucleation in α-synuclein aggregation
por: Staats, Roxine, et al.
Publicado: (2023) -
Editorial: Small molecule inhibitors targeting mammalian selenoprotein thioredoxin reductases (TXNRDs): Interactions, mechanisms, and applications
por: Xu, Jianqiang, et al.
Publicado: (2023)